Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Chlorotrianisene
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Sponsor : Neoantigen Therapeutics
Deal Size : Inapplicable
Deal Type : Inapplicable
Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma
Details : Chlorotrianisene is a Other Small Molecule drug candidate, which is currently being evaluated in Phase I/ Phase II clinical studies for the treatment of Carcinoma, Hepatocellular.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 29, 2025
Lead Product(s) : Chlorotrianisene
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Sponsor : Neoantigen Therapeutics
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Chlorotrianisene
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : Jiangsu Hengrui Medicine
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : TACE is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Carcinoma, Hepatocellular.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 01, 2023
Lead Product(s) : Chlorotrianisene
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : Jiangsu Hengrui Medicine
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Chlorotrianisene
Therapeutic Area : Oncology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : TACE is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Carcinoma, Hepatocellular.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 11, 2022
Lead Product(s) : Chlorotrianisene
Therapeutic Area : Oncology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable